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CANCER COMMITTEE CHAIRMAN’S FOREWORD

In other areas, the Cancer Committee under
took a review of the treatment of prostate
cancer at West Allis.
Patients initially
diagnosed in 1978 were compared to patients
diagnosed in 1988. A substantial improvement
in 5 year survival was documented which
related mainly to the earlier diagnosis of this
common malignancy. The use of prostatic
specfic antigen (PSA) as a screening tool and
transrectal ultrasound as a diagnostic tool have
also greatly increased the chances of finding
this tumor at an earlier stage.
In conjunction with this West Allis participated
in an American College of Surgeons sponsored
study reviewing the short-term and long-term
effects of radical prostatectomy in gentlemen
with prostate cancer. We await the long-term
results from the national study.
Kevin J. Murray, M.D., Chairman
The Cancer Committee also supervised our
participation in both the short-term and longterm patient care evaluation studies of patients
with cancers of the larynx and hypopharynx.
This participation forms the basis for our report
this year and later in this report, you will find
articles describing the surgery, chemotherapy,
and radiation therapy aspects of these types of
cancers.

The Cancer Committee is a multidisciplinary
committee whose function is the overseeing
and monitoring of the overall oncology aspects
at West Allis Memorial Hospital. In addition to
supervising educational efforts for the medical
staff, nursing and the general public, the
committee supervises the submission of data to
the American College of Surgeons who directs
both short-term and long-term patient care
evaluations.

Throughout the past year, the Cancer Program
at West Allis Memorial Hospital has maintained
its tradition of excellence in the therapy and
support of those people afflicted with this
disease. This requires the continued dedication
of all those who participate and I applaud their
excellent work.

Highlights of the past year include the every 3
year survey of our Cancer Program by the
American College of Surgeons for the continued
accreditation. I am pleased to report that our
program has met all of the requirements and
has received an unqualified 3 year renewal.
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INTRODUCTION
for seamless care of the cancer patient. The
goal is to develop a functionally integrated
continuum of care. This requires well devel
oped outreach activities.

The American Cancer Society, Atlanta, esti
mates that one in three Americans now living
(about 83 million) will develop cancer at some
point in their lives. For every 1 ,000 popula
tion, 16 are under medical care for cancer
symptoms, lout will be new cancer cases in
1995 and 300 will develop cancer.

Lifetime follow-up of cancer patients is
imperative. Patients cured of one cancer are
not immune to developing a second. Many
such patients have a higher than average
chance of developing a second primary cancer.

Cancer is the disease of the future. Although
cancer can strike at any age, experts say that
older Americans will continue to account for
the bulk of cases. Meanwhile, the U.S. popula
tion is growing older, and living longer.

Even when there is a recurrence, some patients
have a second chance of cure. Many cancers
now exist in which a significant remission
lengthens useful life as compared to the natural
course of the disease as measured in the past
or as compared to those treated who do not
respond.

In 1971, one in three cancer patients lived five
years or more after their diagnosis. Today,
nearly half will do so, according to the Amer
ican Cancer Society.

The purpose of cancer therapy is not to prolong
suffering. Even when there is no chance of
cure or prolongation of life, cancer treatment
often allows a much better quality of life,
control of pain, and at times prevention of
paraplegia. Many patients with cancer who
used to have prolonged hospitalizations died a
very painful death; they now can have signifi
cant periods of good quality of life at home
under the care of their primary physician.

The Commission on Cancer of the American
College of Surgeons (ACoS) sets the standards
for cancer care in the nation. It has become
one of the most important organizations in the
fight against cancer. For this reason, West
Allis Memorial Hospital sought accreditation of
This
their Cancer Program by the ACoS.
program has been continuously certified since
1978.
Program approval benefits patients, profes
sional staff members, the hospital, as well as
the community. The Cancer Program concen
trates not only on the diagnosis and treatment
of cancer, but on prevention, screening, educa
tion, nutrition, rehabilitation, patient care
evaluation, follow-up, support programs, and
more.

From a purely economic point of view, the cost
savings from eliminating a few days hospital
ization would pay for much outpatient care. A
strong Cancer Program has the ability to
balance quality with cost.
This report of the Cancer Committee of West
Allis Memorial Hospital is an effort to sum
marize the evolving program of this institution
to assure that patients with cancer receive the
best possible care available.

Without an organized program, you don’t really
know what is happening to your cancer
patients. Major emphasis is placed on planning
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TUMOR BOARD
Weekly Conferences
Tumor Boards are held every week at noon on
The luncheon conferences bring
Fridays.
isciplinary group of physicians
multid
a
r
togethe
professionals to discuss
health
allied
and
and current methods of
cases
cancer
ual
individ
ent.
treatm
and
sis
diagno

provide opportunities for discussion of research
eligibility, improve effectiveness of allied health
personnel in caring for cancer patients, identify
possible community needs for education,
screening, detection and prevention clinics.
Tumor Board provides a mechanism for review
of professional practices within the hospital for
the purpose of reducing morbidity and mortality
through outcome analysis.

Case Presentations

Attendance

The cases are presented by attending physi
cians. Pathologists show slides of the tumor
specimens and radiologists show and review
the radiographic studies that were performed.
These case presentations are both current and
prospective, and offer the attending physicians
the opportunity to request recommendations for
patient management. Prospective case review
assures the newly diagnosed patient access to
multidisciplinary pretreatment evaluation,
accurate staging of disease, treatment manage
ment, and follow-up evaluation.

In 1994, 166 cases were presented at Tumor
Boards, an average of over three patients per
week. There was an average of 35 persons in
attendance each week. The cases presented
were representative of all major cancer sites
treated at West Allis Memorial.

Conference Benefits
The case reviews generate new knowledge,
provide a review of basic cancer management
principles, identify areas for audit review,

Continuing Education Credit
The Tumor Boards and Continuing Medical
Education programs presented each Tuesday
are approved for continuing education credit by
the Wisconisin Medical Association, and the
American Academy of Family Practice for one
credit hour in Category I of the Physicians’
Recognition Award of the American Medical
Association.

Cancer-Related Continuing Medical Education Programs
Date

Subject

Speaker

1/11/94

Chronic Lymphocytic Leukemia

Maury Berger, M.D.

3/8/94

Prostatic Cancer: Utilization
of Prostate Specific Antigen in
its Detection and Monitoring

Christopher Kubat, M.D.

5/24/94

Bone Marrow Transplantation in
Patients with Breast Cancer

Robert Taylor, M.D.

7/26/94

Prostate Cancer
it All Mean?

9/13/94

Recent Advances in Early Stage I
Lung Cancer

Ronald Hart, M.D.

Controversies Regarding Screening
and Treatment in Prostate Cancer
1

Mark Rosen, M.D.

11/1/94

-

PSA: What Does

John Pope, M.D.

CANCER REGISTRY
Surgeons long and short-term study reporting
are accomplished by computer diskette.

Name Change
The Tumor Registry name has been changed to
Cancer Registry. This name is more represent
ative of its function and is more in line with
state and national registry associations recent
name changes.
The Cancer Registry is a
cancer data services department.

Cancer Committee Activities
The registry works closely with the Cancer
Committee. Under the auspices of the Cancer
Committee, the registry assures that all
components for an approved Cancer Program
are maintained.
The registry assisted the
Cancer Committee in collecting data for the
American College of Surgeons tACoS) and long
and short-term larynx, hypopharynx studies.
The results of the larynx and hypopharynx are
reported in another part of this report. Data
were also collected for participation in a
research study with the Blood Center of
Southeastern Wisconsin entitled: Trial to
Reduce Alloimmunization to Platelets (TRAP)
study.

Computerized Records
The registry utilizes computers and a software
program of Electronic Registry Systems for on
line abstracting, follow-up, and reporting. The
information collected is grouped in four general
categories;
Patient Identification:
Over 25 items are
collected including age, sex, race, marital
status and demographic data.
Cancer Identification: Primary and secondary
site, histology, stage at the time of diagnosis,
extent of disease and diagnostic methods are
collected.

Database
Since January 1, 1978, the registry has acces
sioned over 1 2,000 new cancer cases. In
1994, 882 new cancer cases were added to
the registry.
Lifetime follow-up rate was
maintained at an average of 94%. Lifetime
follow-up gives physicians a continuous
perspective of the results of treatment
strategies utilized.

Cancer Treatment: Treatments rendered at the
time of diagnosis and any subsequent treat
ment rendered for recurrent disease are
recorded by modality. Names of physicians
who treated the patients are also collected.
Follow-up Information: All patients diagnosed
and/or treated at West Allis Memorial are fol
lowed by the registry for the lifetime of the
patient.
The information collected includes
whether the patients are alive or dead, with or
without cancer, the quality of life during their
survival time, and their disease-free survival
time. Follow-up letters to physicians are
computer-generated.

Continuing Education
Registry staff, in addition to attending weekly
Tumor Boards, also attended the 26th Annual
Southeastern Wisconsin Cancer Conference in
Milwaukee, a TNM staging workshop in Rhinelander, WI., and the 19th Annual Wisconsin
Cancer Registrar’s Association Conference in
Marshfield, WI. These meetings provided train
ing and invaluable information on changes in
the cancer registry data collection require
ments, as well as current changes in cancer
diagnosis and treatment.

Reporting Capabilities
Cancer incidence, survival and treatment
graphics and statistical reports are possible
from any combination of the data items col
lected. This can be accomplished through both
“canned” reports and/or adhoc reports to
complete any individualized requests. National
Cancer Data Base (NCDB), Wisconsin Cancer
Registry System, and American College of

Requests for Information
During 1 994, twenty-one requests for registry
information were received. The registry staff
welcomes the opportunity to assist medical
staff members to retrieve cancer data.
2

WEST ALLIS MEMORIAL HOSPITAL
CANCER PROGRAM
RESEARCH

TREA TMENT SERVICES

Institutional Review Board
Clinical Trial Protocols
Cancer Registry
National Audit Participation

Inpatient Oncology Unit
Outpatient Oncology Unit
Inpatient and Outpatient Surgery
Laser Surgery
Laparoscopic Surgery
Chemotherapy Administration
Immunotherapy
Hormone Therapy
Blood Administration
Radiation Therapy
Linear Accelerator
Brachytherapy
Computerized Treatment Planning
Radiologic Diagnostic Technology
X-ray
CT scan
Magnetic Resonance Imaging
Ultrasound
Radioisotope scans
Dedicated Mammography
Diagnostic Laboratory Services
Histology and Cytology
Hematology
Microbiology
Immunohistochemistry
Urinalysis
Serology
Industrial Toxicology
Coagulation
Emergency Care Services

ANCILLARY SERVICES
Oncology Nursing Services
Enterostomal Therapy
Physical Medicine
Physical Therapy
Occupational Therapy
Speech Therapy
Pulmonary Laboratory
Nutritional Services
Pharmacy
Home Care Services
Biofeedback Therapy
Support Services
PA TIENT AND FAMILY SUPPORT SERVICES
WAMH Van Transportation
Home Laboratory Services
Home Care Program
Meals Ala Wheels
Positive People Support Group
Caregivers Support Group
Living Through Loss
Pastoral Services
Financial Counseling
Hospice Care
Medical Equipment and Supplies
Patient Education
Lifeline
Mastectomy Teaching
Enterostomal Teaching
Thlecare

COMMUNITY SERVICES
Stop Smoking Programs
Breast Cancer Screening Clinic
Physician Referral Service
Health Information Services
Prevention and Screening Programs
Cancer Information Services
Senior Services Program

ACCREDITATiONS
American College of Surgeons,
Commission on Cancer
Joint Commission on Accreditation of
Healthcare Organizations
College of American Pathologists

PROFESSIONAL EDUCA TION
Tumor Boards
Continuing Medical Education Programs
Oncology Nursing Inservices
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ACCESSION YEAR DISTRIBUTION
1978- 1994
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ACCESSION YEAR
*Analytic cases are those which were diagnosed and/or treated at WAMH. Non-analytic cases are those
which were diagnosed and had their 1st course of therapy elsewhere and were seen at WAMH for recur
rence and/or subsequent treatment.

WEST ALLIS MEMORIAL HOSPITAL
PRIMARY SITE TABULATION FOR 1994 ACCESSIONS

PRIMARY SITE

ALL SITES

STAGE
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TOTAL
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0
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2
0

A

N/A

M

F
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2
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0

0

0
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WEST ALLIS MEMORIAL HOSPITAL
PRIMARY SITE TABULATION FOR 1994 ACCESSIONS
TOTAL

PRIMARY SITE

CLASS

SEX

A

N/A

M

F

INS

LOC

REG

STAGE
01ST

BEN

UNK

MALE GENITAL

145

144

0

1

104

26

10

139

0

1
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23

8
8

0
0

6
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10

PROSTATE
TESTIS

4
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4
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0

1

3

0
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0
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1

1

0

1

0

0

1

0

0

0

0
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URINARY SYSTEM

6

9
6

24

14

33

8

5

0

2

44
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38

38
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28

16
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2

1

0

2
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0

0
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7

5

1

1

0

1

1

0

0
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0

5
0

1

0

4
0

0
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7
0

4
4

0

8

1
1

4

THYROID

0

0

0

1
0

32

30

2

15

17

0

4

7

17

0

4

5
25

0
2

0
15

5

NON-HODGKIN’S

5
27

12

0
0

0
4

2
5

1
16

0
0

2
2

UNKNOWN PRIMARY

11

10

1

4

7

0

0

0

0

0
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3

3

0

1

2

0

1

2
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HODGKIN’SOISEASE

OTHER/ILL-DEFINED

KEY
CLASS A

ANALYTIC CASE PATIENTS DIAGNOSED AND/OR RECEIVED ALL OR PART OF THEIR FIRST COURSE OF
THERAPY AT THIS HOSPITAL

CLASS N/A

NONANALYTIC CASE PATIENTS DIAGNOSED AND TREATED ELSEWHERE WHO WERE SEEN AT THIS HOSPITAL
FOR RECURRENCE OR PERSISTENT DISEASE OR WERE FIRST DIAGNOSED AT AUTOPSY

STAGE INS

IN SITU STAGE

STAGE LOC

LOCAL STAGE

STAGE REG

REGIONAL STAGE
LYMPH NODES

STAGE DIST

DISTANT STAGE

STAGE BEN

BENIGN TUMORS

STAGE UNK

UNKNOWN STAGE

-

-

NONINVASIVE CANCER

-

-

CANCER CONFINED TO THE ORGAN OF ORIGIN

-

DIRECT EXTENSION OF CANCER INVADING BEYOND THE ORGAN OF ORIGIN AND/OR REGIONAL

-

DISCONTINUOUS EXTENSION OF CANCER TO SURROUNDING OR DISTANT ORGANS AND LEUKEMIAS

-

STAGING WORKUP WAS NOT COMPLETED
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WAMH 1994 ANALYTIC CANCER CASES

In 1994, 54 percent of the
cancer patients were female
and 46 percent were male.
Respiratory system cancers
were 50 percent more com
mon in men than women.
Men had twice the incidence
of oral cavity cancers. Sexrelated organs for both sexes
continued to be the most
common sites for cancer.
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Women continue to be diagnosed at an earlier
stage than men. The majority of the in situ
cancers in women are of the breast and cervix.
This is in direct relationship to effective
screening methods, including the Pap smear
and mammography.

Surgery remains the most common treatment
for cancer, followed by radiation therapy and
chemotherapy. This also reflects the fact that
the majority of the cancers are diagnosed at an
earlier stage when surgical or radiation therapy
can provide a cure.

The unstageable category includes those sites
that do not have a staging scheme such as
leukemias and unknown primaries. This cate
gory also includes those patients for whom a
complete staging work-up was not possible, for
whatever reason.

In reviewing treatment combinations, surgery
was combined with other treatment modalities
for 200 patients. Radiation therapy was used
in combination with other modalities of treat
ment for 162 patients. Chemotherapy was
used in combination therapy for 123 patients.

1994 ANALYTIC CANCER ACCESSIONS
AJCC TNM STAGE BY SEX

STAGE AT DIAGNOSIS
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PHARYNX
INCIDENCEAND THERAPY FOR CARCINOMA OF THE LARYNXAND HYPO
By Donald S. Blatnik, M.D.
tobacco markedly elevates the risk for these
There also seems to be some
cancers.
increased risk in metal workers, asbestos
workers and possibly textile processors.
Patients who have a cancer of the larynx have
about a 3.5% incidence of having another
simultaneous primary in the head and neck, a
4% incidence of having a simultaneous primary
in the lung, a 2.4% incidence of having another
simultaneous primary somewhere else in the
body. Patients with cancer of the larynx have
a previous history of cancer in the head and
neck in 1 .6% of cases, a previous history of
lung cancer in 1 .5% of cases and a history of
cancer elsewhere in about 7% of cases.
Patients with a diagnosis of cancer of the hypo
pharynx have a 6.7% incidence of having
another simultaneous primary in the head and
neck. They have a 4% incidence of having a
simultaneous primary in the lung, a 3.9%
incidence of having a simultaneous primary in
the esophagus and a 3.7% incidence of having
a simultaneous primary in another area of the
body. Patients with cancer of the hypopharynx
have a 5% incidence of a previous head and
neck cancer, a 1 .6% incidence of a previous
lung cancer and a 8.5% incidence of having
had a previous cancer to another site of the
body. For these reasons, it is important to
evaluate these patients for other primary
tumors at the time of their diagnosis, as well as
in follow-up.

Donald S. Blatnik, M.D.
Carcinoma of the larynx and hypopharynx
makes up about 3% of the malignancies
diagnosed annually. It had a 7:1 predilection
It is now a 4:1
for mates over females.
The incidence in the female
predilection.
populations is rising, as is the smoking history
in the female population. Eighty percent of
these cancers occur between ages fifty and
eighty. At least fifty percent of the cancers
arise from the vocal cord area. Vocal cord
cancers fortunately present very early with
hoarseness and have a very high cure rate
because of this presentation. The carcinomas
that do not arise from the vocal cords
frequently present with dysphagia, sore throat
or otalgia and as a result, are diagnosed later
and are more advanced. Some of the tumors
present with a mass in the neck at an even
later stage and have a much poorer prognosis.

LARYNGEAL CANCER
Ti carcinoma of the vocal cords has a high
cure rate of 80 90% with radiotherapy. This
is frequently diagnosed early because of its
early presentation of hoarseness. The in situ
carcinomas and small cancers of the vocal
cords can be treated simply with C02 laser
therapy which is both expeditious and has an
equally high cure rate. If the lesions extend to
the anterior commissure or onto the arytenoid,
radiotherapy is the method of choice. When
there is deeper infiltration the voice is better
with radiotherapy, but the treatment is much
-

There is a higher incidence of carcinoma in the
black population than in the white population.
Carcinoma of the larynx and hypopharynx has
a very low incidence in nonsmokers. There is
a higher incidence of cancer of the larynx in
alcoholics. The exposure to both alcohol and
11

more expeditious with the C02 laser treatment
and thus, patient’s choice should be con
sidered.

indicated. Supraglottic lesions frequently do
have bilateral metastases when they are of
significant size, therefore, both necks have to
be treated. Neck dissections for cancer in the
head and neck are usually modified.
The
classical radical neck dissection is not done
very often.

T2 carcinomas of the larynx are usually treated
with radiotherapy because of the better voice
quality. However vertical hemilaryngectomy
can also be used. The larger T3 and T4
cancers of the vocal cords are frequently
treated with surgery of various types, followed
by radiation therapy. In some instances a near
total laryngectomy can be done creating a
shunt connecting the trachea and hypopharynx
so that the patient can speak. If this procedure
cannot be done, a tracheoesophageal shunt
tube can be inserted connecting the trachea
and esophagus. This can give very satisfactory
voice in most total laryngectomy patients.
There are still a few patients that require the
use of esophageal speech or in rare instances,
that use a vibrating external device to create
speech.

HYPOPHA RYNGEAL CARCINOMA
Cancer of the hypopharynx including the
pyriform sinuses is generally found at a much
later stage because of its presentation with
dysphagia. Hoarseness is only found in the late
stage of the disease when it has invaded the
intrinsic larynx and vocal cords. These tumors
have a higher incidence of neck metastases.
They are frequently treated with laryngopharyn
gectomy, neck dissection and radiation therapy
because of their more advanced stage. At
times, a near total laryngectomy can be done
when a portion of one vocal cord can be saved.
These patients then can speak by means of
their surgical shunt. If that is not able to be
performed, tracheoesophageal shunt tubes can
be placed to give patients satisfactory speech
in most instances. The extremely large cancers
of the larynx and hypopharynx can be treated
with total laryngopharyngectomy and chest
flaps or microvascular flaps. Sometimes gastric
pull ups or microvascular bowel anastomoses
are done. These procedures can be very pro
longed and obviously the cure rates are
diminished.

Supraglottic carcinomas are the cancers that
are above the vocal cords. The early lesions, Ti
and T2, are generally treated by means of
radiation. Frequently, however, these lesions
present late and are more advanced. When
they are more advanced both surgery and
radiation are indicated. In some instances a
supraglottic laryngectomy preserving the vocal
cords can be done, however, some of these
patients do have problems with aspiration. If
the patient has significant chronic obstructive
pulmonary disease this procedure is contra-
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RADIA TION THERAPY FOR CARCINOMA OF THE LARYNX AND HYPOPHARYNX
By Kevin J. Murray, MD.
beam approaches. Surgical procedures including
endoscopic procedures, laser excision, cord
ectomy, hemilaryngectomy or supraglottic
laryngectomy have been used to maximize
voice preservation. Total laryngectomy is
necessary for the treatment of advanced
carcinomas and results in complete loss of
normal voice function. Recently, chemotherapy
has been combined with radiation therapy and
has been used to improve the treatment of
advanced operable laryngeal cancer with the
goal of increasing organ preservation.
Selection of treatment for the individual patient
depends on the number of factors including the
site and extent of disease, the mobility of the
vocal cords, whether there is invasion of
surrounding structures, growth characteristics
of the tumor, histology, general medical
condition of the patient, and patient prefer
ences.

Kevin J. Murray, M.D.
Anatomically, the larynx is contiguous with the
pharynx above it and is connected with the
trachea below it. It extends from the tip of the
epiglottis at the level of approximately the C-3
vertebral body to the lower border of the
cricoid cartilage at the level of C-6. The larynx
is divided into 3 anatomical regions including
the supraglottis, glottis, and subglottic areas.
Cancers of the subglotic area are relatively rare
and will not be mentioned further. The supra
glottic area can be subdivided into the epi
glottis, aryepiglottic folds, arytenoids, and false
cords. The glottis consists of the true vocal
cords, their connection anteriorly at the anterior
commissure as well as the posterior commis
sure. The hypopharynx extends on either side
of the larynx and includes the pyriform sinus,
pharyngeal wall and the posterior cricoid area.

Generally, early lesions of the vocal cords can
be treated successfully with either surgery or
radiation. Advanced lesions generally requite
surgery with or without the use of postopera
tive irradiation. Exophytic lesions are usually
more responsive to radiation therapy than infil
trative lesions. Radiation alone or combined
with surgery may be the preferred treatment for
poorly differentiated carcinoma.
At West Allis we are participating in a number
of national studies looking at various treatment
approaches in cancers of the larynx and hypo
pharynx. The majority of these are sponsored
by the Radiation Therapy Oncology Group. The
first study is a Phase Ill or randomized study to
compare the long term success with 4 different
types of radiation therapy delivery. The first
utilizes a standard radiation therapy approach
of one treatment per day, five days per week
for a total of approximately 7 weeks. The
second approach uses two treatments of a
slightly lower dose per each treatment. This
then results in slightly more radiation per day
than the standard approach. The treatments
are again five days a week for approximately 7

The objective of treatment for carcinoma of the
larynx and hypopharynx is to obtain the best
cure rate with the optimal preservation of
Radiation
function (namely, voice quality).
therapy and surgery alone or in combination
have been the primary treatments for
carcinoma of the larynx and hypopharynx.
Radiation is traditionally delivered with external
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laryngeal function (i.e. namely voice quality).
Other endpoints include an evaluation of the
response of the tumor to the chemotherapy
agents that ace given, determination of differ
ence in the type of relapse that may occur, and
whether the use of combined radiation therapy
and chemotherapy is associated with a signifi
cant increase in both short term and long term
side effects of therapy. This study is relatively
recent and has accrued approximately 200
patients and will continue to be open for the
next 4 5 years.

weeks. A third approach uses two treatments
per day but each treatment is close to the size
of the standard radiation therapy treatment.
This results in a great increase in the amount of
radiation per 24 hour period. However, this is
associated with an increase in side effects as
the patient continues through the radiation
therapy treatments. Patients are therefore given
a small break in the middle of their treatment to
allow for some of their side effects to resolve.
The last of the four approaches uses two treat
ments per day but the first treatment in the day
is given to a large treatment field to encompass
the tumor plus the areas of potential likelihood
of spread. The afternoon treatment however is
more focused on the area of tumor alone.

-

Lastly, a very interesting area has begun to be
explored. This is whether or not there are drugs
that will prevent actual tumors from starting
(otherwise known as chemoprevention). It is
well known that patients who develop an initial
cancer of the mouth, throat, and voice box are
at a significant risk for development of the
second tumor. In the laboratory, the use of
retinoic acid has been documented to decrease
the development of these second cancers.
Currently, approximately 700 patients including
some from West Allis, have been entered on
this study to see if the daily administration of
retinoic acid will prevent the development of a
second cancer 1 2 years in the future.

This study is proceeding exceedingly well with
over 700 patients enrolled in this study nation
ally. West Allis Memorial has contributed
several patients to the ongoing effort in this
regard.
A second approach that is being done for some
tumors of the larynx is an approach to try to
preserve the larynx using a combination of
chemotherapy and radiation therapy. The major
endpoint is the evaluation of long term survival
with associated preservation of normal

-
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CHEMOTHERAPY FOR HEAD AND NECK CANCERS
By Robert F. Taylor, M.D.
the 1980’s. The third evolution of chemother
apy has been its use in an adjuvant setting,
either in sequence or simultaneously with radio
therapy. Finally, as organ preservation becomes
mote of an important issue, the use of either
chemotherapy alone or chemotherapy given
concurrently with radiation has been dis
covered.
Treatment of Advance Disease
As palliation for advanced disease, chemother
apy has received considerable use in the past
several years. Several different combination
chemotherapy regimens have been used includ
ing Cisplatinum, 5FU, Bleomycin, methotrexate.
By-and-large, the use of platinum based chemo
therapy combinations have been the most ef
fective and widely utilized and yield superior
results to single agent therapy such as metho
trexate. Median survival time for treatment of
patients with advanced or recurrent disease,
treated in this fashion ranges between five to
six months, with 5FU/Cisplatinum being the
most favored of the combinations.

Robert F. Taylor. M.D.
Approximately 43,000 cases of invasive head
and neck cancer are diagnosed annually in the
United States. Two-thirds of these patients
have either stage Ill or stage IV disease at the
time of involvement with either large primary
tumors and/or regional lymph nodes. Surgery
and radiation therapy are considered standard
treatments at the present time; however, be
cause of the unacceptably high recurrence rates
(between 60 and 100%), other possibilities are
obviously needed. In addition, second tumors
occur at a constant rate of 3 to 4% a year and
therefore represent another threat to such
patients.

Recently carboplatin has been used instead of
Cisplatinum in these combinations and has
been found to be equipotent. Carboplatin, be
cause it can be given as an outpatient and is
less nephrotoxic, has a great appeal, partic
ularly in a group that may be elderly and may
have impaired renal function. Utilizing either the
Calvert or Egorin formulas, these drugs can be
given safely to patients with impaired renal
function. A relatively new agent, paclitaxel
(Taxol), has also been used in head and neck
cancer and has shown favorable activity. In
fact, some studies suggest that Taxol may be
the most effective single agent used in this ap
proach.

Over the past two to three decades, the role of
chemotherapy in such patients has evolved
considerably from its accepted indication as
palliative therapy for recurrent disease to a
more front line component in patients with
initially advanced disease. The addition of
Cisplatinum to the combination chemotherapy
regimen in the 1970’s greatly improved the
response rates, and subsequent attempts at
concurrent chemo-radiotherapy, utilizing Cis
platinum based chemotherapy, were initiated in

Neo-adjzwant Chemotherapy
The use of Cisplatinum based chemotherapy
results in an average overall response and CR
response rates of approximately 85 and 35%
respectively. A number of randomized clinical
trials, comparing induction chemotherapy fol
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lowed by surgery and radiation therapy, have
been published and reviewed. No significant
differences in survival have been demonstrated
with the use of adjuvant chemotherapy;
however, the major cause of failure in these
patients has been the failure of the combined
modality therapy to improve local regional con
trol of disease. Several trials have shown a
decrease in the instance of distant metastatic
disease but, because of the great tendency of
these tumors to recur locally, overall survival
has not been affected.

disease at any time was observed in patients
receiving adjuvant chemotherapy. In addition a
high risk group of patients was identified in
whom both local regional control and survival
differences approached statistical significance.
Concurrent Chemo-radiotherapy
Another role for chemotherapy in head and
neck cancer has been as a means of sensitizing
tumor cells to the effects of ionizing radiation.
Disease-free and overall survival for single
agent 5FU/bleomycin and mitomycin combined
with radiotherapy have been shown. Cisplatin
and carboplatin provide another opportunity to
demonstrate the synergy, because neither
agents aggravate mucositis as a primary tox
icity. Platinum based chemotherapy has been
tested, primarily in patients with locally ad
vanced unresectable disease, and several
studies show a significantly higher overall
response rate in patients with combined
modality treatment. Unfortunately again, there
was no overall impact on survival. The RTOG
utilized an alternating dose and scheduling of
Cisplatinum with complete response rate in 1 24
or 71 %. The four year survival rates were com
pared with the standard therapy without
chemotherapy and showed an improved
response rate. The use of chemo/radiotherapy
obviously deserves additional attention, as do
the use of other potential radio-sensitizing
agents.

When used in patients who are considering
organ preservation, the combination of Cis
platinum and 5FU followed by radiation therapy
in those patients who responded to chemother
apy was compared with laryngectomy and
postoperative radiation. The CR rate, after three
cycles of chemotherapy, was 65%. Diseasefree survival was identical in the chemotherapy
treated arm and the radical surgery arm, sug
gesting that organ preservation can be achieved
in patients with high risk tumors through the
use of this combination without sacrifice of
long-term disease-free survival. Therefore,
induction chemotherapy followed by radio
therapy still has a defined role as an alternative
treatment to total laryngectomy in advanced
squamous cell carcinomas of the larynx, in
patients desiring preservation of speech. More
effective chemotherapy agents, as well as opti
mization of other methods for local regional
control, are obviously still needed.

In conclusion, the use of chemotherapy in head
and neck cancer has evolved, both in terms of
the drugs that have been used to treat these
diseases and the methods whereby the treat
ment is administered. It appears likely that
chemotherapy may reduce the risk of distant
metastatic disease but, because of the persist
ent high risk for local regional recurrence of
these diseases, the overall effect on survival
has been diminished. Clearly, better means of
controlling these diseases locally will be
necessary before substantial improvements in
overall and disease-free survival can be realized.

The use of adjuvant chemotherapy for patients
who have been rendered free of disease via
surgery has been only tested in one large ran
domized clinical trial. In this study, patients
with resected stage III or stage IV squamous
cell carcinoma of the oral pharynx, larynx or
hypopharynx were randomized to receive imme
diate radiotherapy or three cycles of adjuvant
chemotherapy followed by radiotherapy. While
analysis showed no difference between the two
arms in terms of overall survival, a significant
reduction in the incidence of distant metastatic
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REHABILITA T1ON ISSUES IN LARYNGEAL CANCER
By Dr. Linda Barro ws, Ph ysiatrist
bladder, pancreas and esophagus. Other factors
such as industrial exposure to toxins, such as
may be found in the metal, lumber, railroad or
farming industries, genetic predisposition,
viruses and accidents might also play a role.
Squamous cell carcinoma of the larynx is the
most frequent cancer of the upper air and food
passages. Often hoarseness, or change in the
sound of the voice is the first evidence of
laryngeal disease, prompting early diagnosis
and successful treatment. But cancers arising
above and below the true vocal folds may give
no early warning and are often larger when
detected. One may have only a vague sore
throat, pitch change or a reduction of loudness
of voice, referred ear pain, difficulty with
swallowing, a lump in the neck from
metastasis, but no hoarseness until later on.
When detected at an early stage, cancer of the
larynx is one of the most curable of all cancers.
For smaller tumors, particularly those on the
vocal cord, radiotherapy may be the treatment
of choice and is less ablative than surgery. The
extent of normal tissue resected in the larynx
depends on the site of the malignancy given
the lymphatic drainage to the region. Tumors
are staged according to size, status of lymph
nodes and for distant metastases. In carefully
selected patients treatment may include
conservation surgery with preservation of a
functional larynx. Only a relatively small
number of these procedures will require
extensive vocal rehabilitation.

Linda J. Barrows, M.D.
INTRODUCTION
Over 8 million Americans alive today have a
history of cancer. Of these, 5 million were
diagnosed five or more years ago, most of
whom are now considered cured. This year
1,252,000 new cancers will be diagnosed
(excluding carcinoma in situ, basal and
squamous cell skin cancers).
Approximately 9,000 males and 2,600 females
cases will be diagnosed with cancer of the
larynx this year, with a 4:1 male to female ratio
and average age at onset of 63 years. Today
more conservative management of early
cancers is possible, such as being able to spare
the voice in cancer of the larynx. Survival rate
continues to improve for laryngeal cancer,
especially if lesions on vocal cords are found
early. Increasing numbers of long term
survivors will now face quality of life issues.

A total laryngectomy may be required for some
advanced tumors or if radiation treatment fails
to control the laryngeal cancer. In some cases,
a radical neck dissection, preoperative or
or
therapy
radiation
postoperative
chemotherapy may also be required.
The surgeon and speech therapist may provide
the patient and spouse with valuable
information before surgery, when it is easier to
communicate effectively. The patient can be
instructed about the alterations of physiological
functions of speech and swallowing, types of

Smoking and drinking are two leading risk
factors for laryngeal cancer, especially if
combined. Smokers are also at risk for
carcinomas of the lung, mouth, tongue, lip,
17

available replacement speech, as well as the
appearance that cancer treatment may produce.
Treatment may involve relearning basic skills,
such as swallowing and working with a speech
master
new
forms
of
therapist
to
communication. To also help inform and ease
anxiety, preoperative or postoperative hospital
visitations with a volunteer from the American
Cancer Society who has had a laryngectomy
can be arranged, if surgeon has requested or
approved it.

may include changes in head positioning while
swallowing, determination of consistency of
food best handled or exercises to improve
tongue and jaw range of motion, or improve
laryngeal closure.
Tumors located on one vocal fold, and treated
with a vertical or hemilaryngectomy, leaving
the epiglottis intact may cause little difficulty
with swallowing. Initially a head flexed posture
may help protect the airway. Supraglottic
tumors may be treated with a partial (horizontal
or supraglottic) laryngectomy. This spares the
true vocal folds, which the patient must then
learn to occlude for airway protection during
swallowing. Vocal fold add uction exercises can
be given, and a sometimes a Teflon injection
into the vocal cords considered. If the
procedure is extended posteriorly to include the
arytenoid cartilage, one may never be able to
swallow liquids. Additional swallowing training
is also required if surgery is extended up
towards the base of the tongue. If a superior
laryngeal nerve is sacrificed, problems could
result from a decreased cough and a reduced
awareness of aspiration.

Educational materials may be obtained from the
A.C.S. and the International Association of
Laryngectomees, which they sponsor. A few of
services
available include
the
other
transportation assistance in getting to and from
treatments, home care supplies and equipment,
the “Look Good...Feel Better” program to
develop skills to cope with appearance
changes, and the “I Can Cope” program with
information to patients and families. West Allis
Memorial Hospital also offers cancer support
group meetings for patients as well as their
families and friends.
Postoperatively, skilled nursing intervention can
help one learn the daily management of devices
such as tracheostomy tubes and voice
prostheses. Information is provided regarding
stoma care and coverings, bathing precautions,
and the need for adequate hydration and
humidification,
appearance and personal
hygiene. Recommendations regarding making
adjustments in eating, along with suggestions
from the dietitian and speech therapist, are
provided. There will be education regarding
potential problems and the type of follow-up
care required.

Large lesions, involving more than one region,
This
usually require a total laryngectomy.
removes the larynx (voicebox) which is in
volved not only in the production of speech,
but also in protecting the airway. The trachea
is then connected to a tracheostoma for breath
ing and to protect it. With the resulting physical
separation of the gastrointestinal from the
respiratory tract, there will be no risk of aspira
tion. Some prosthetic voice procedures, how
ever, could create a risk of some aspiration.
LARYNGECTOMY AND SPEECH REHABIUTA
TION

CANCER OF THELARYNXAND SWALLOWING

Both verbal and nonverbal communication allow
expression of a variety of emotions. Following
total laryngectomy, one is no longer able to
shout, laugh, sing, attract attention or help by
yelling or shouting. Speech loss is usually the
most traumatizing change associated with
being laryngectomized. Many appear to become
more concerned about their loss of voice than
their cancer diagnosis, and this also comes at
a time when they need to communicate their
anxieties. Acquiring any form of useful verbal
decrease
communication
may
therefore

Effects on swallowing varies according to the
type of treatment required for the cancer of the
larynx. Postoperatively a videofluoroscopic
examination can be conducted if necessary to
assess for presence and type of dysphagia.
For some there may be only some mild
dysphagia shortly after surgery. Many require
nothing more than reassurance or some minor
changes in diet. Dysphagia may exist due to a
compromise of lingual or pharyngeal function
due to anatomical changes. Swallowing therapy
18

coupling, timing, articulation, rate and phrasing,
pitch and loudness. These methods require one
hand for operation, the need to have a device
available, and the speech may sound
monotonous and artificial. One should be able
to try various types of artificial larynx before
making a selection.

frustration and depression.
Following laryngectomy one will be unable to
speak in the usual manner as there are no vocal
cords to vibrate. Even larynx conservation
surgery may affect the quality of speech. A
partial hemilaryngectomy may result in breathmess, harsh speech and hoarseness. A subtotal
supraglottic laryngectomy also results in some
hoarseness, but there is good intelligibility with
both procedures. Radiation therapy can also
affect quality of voice due to possible resultant
stiffness of the vibratory source.

Another main method of communication after
laryngectomy is to trap air into the esophagus
to produce sound when released. One must
learn to relax the esophageal sphincter when
inhaling, allowing air to be pulled into the
esophagus but not swallowed into the
stomach. The stoma can be covered with a
finger so that air is drawn into the esophagus
from pharynx. The eructation mechanism is
used, which is located in the hypopharynx. Air
is then expelled and sounds are then articulated
orally.

Speech rehabilitation often involves presurgical
counseling. The three main methods of verbal
communication following a laryngectomy are an
artificial larynx, esophageal speech, or a
tracheoesophageal prosthesis. Initially one can
start with writing on pad or slate, or use a
picture communication board. Once cleared by
the surgeon for beginning speech rehabilitation,
an artificial larynx may be especially helpful
immediately post operatively, until sufficient
voice develops for everyday speech.

Esophageal speech can be difficult to learn,
taking three months or more for fluency. It
lacks volume and may be difficult to use over
the phones. The voice is also adversely
affected when eating. It is important to relax,
as anxiety, fears and eagerness to talk make
speaking more difficult. Some will achieve
excellent results, the majority can use it to
some degree, but others are unable to learn
this. First one learns sounds, then advances to
words with longer syllables, phrases and
sentences.

Vibration can be set up from an outside source,
such as an “artificial larynx” or device used to
produce sounds to transmit to the vocal tract.
Because the intact larynx generates
undifferentiated sound, any complex sound can
be put in the upper airway and molded into
speech. The vowels and consonants are then
formed by adjustments of the pharynx, velum,
tongue, mandible and lips.

Because this requires no artificial device, many
find this more desirable. It allows both hands to
be free and gives a more normal appearance.
Some speakers may use this as their only
method of speech, while others use alternately
with the electrolarynx, depending on the
circumstances.

There are two main types of artificial larynx.
The “mouth-type” delivers sound directly to the
mouth by a short tube while the “neck-type” is
designed to have the vibrating disc held against
neck and resonate in the throat. This can
provide an immediate voice once cleared by the
surgeon.

The third main method of communication is the
tracheoesophageal puncture or fistula
(TEP/TEF). Here there is a surgically created
fistula between the rear of the trachea and the
front wall of the esophagus. Various types of a
silicone prosthesis can be used to stent the
fistula. Fluids may leak from the pharynx or
esophagus back into the trachea, risking
aspiration. One problem is that a finger must be
used to close the tracheal stoma to produce
sound, unless wearing a tracheostoma valve. A
special diaphragm can be used to keep the

They may be electronic (battery powered), or
pneumatic (breath powered) where one end is
placed over the stoma. In exhalation, air then
passes over a rubber diaphragm which vibrates
and generates sound that is transmitted by a
flexible tube into the mouth. The careful
articulation required to speak well is also
helpful to learn in preparation for esophageal
speech. Further speech therapy is required as
one must learn the best placement, amount of
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airway open for respiration but will close and
divert the air if exhaling with extra force.

reduce inhalation of dust or particles, and can
also be used to enhance appearance.

Because these allow the use of pulmonary air
for speech, rather than just small quantities of
trapped esophageal air, some of the speech
characteristics are better than with esophageal
speech. This type of speech is highly intelligible
and fluent, with normal length sentences, and
increased intensity and duration. This method
is easy and rapid to learn, with success
reported well over 80%. To be a candidate for
this, one does need sufficient motivation,
cognition, vision and motor control to insert
and care for the prosthesis or occlude the
stoma.

If a radical neck surgery was required, this
would sacrifice the spinal accessory nerve in
order to remove all the involved lymph nodes.
A flaccid paralysis with atrophy of the trapezius
and sternocleidomastoid muscles occurs. One
may then experience subluxation of the
shoulder joint or shoulder pain. This may
require early support, then progressive range of
motion and strengthening exercises for the
remaining normally innervated muscles. Cervical
range of motion exercises can prevent deviation
of spine to the other side. There may be loss of
sensation to skin of lower scalp, top of
shoulder and around ear, with increased risk of
sunburn or frostbite.

A few may remain aphonic after surgery and
lack ability, training or desire for artificial larynx
or esophageal speech use. The Lost Chord or
New Voice Clubs by American Cancer Society
and the International Association of
Laryngectomies are available for instruction,
practice and recreation. It can be beneficial to
attend these local meetings with a spouse or
other family member. Group treatment and
home practice with spouse and family may be
helpful to improve quality of speech. The family
must also learn to understand his mode of
communication and not to speak for the
laryngectomy patient.

There may be a decrease in stamina, which
along with inability to perform adequate
valsalva maneuver, limits ability to perform
strenuous physical work. This could be due to
physical limitations in thoracic fixation for
lifting, or one may tire more easily or become
breathless more quickly. A physical or occupa
tional therapist could provide one with a series
of exercises to improve function.
Since one can not inhale through the nose,
sense of smell is reduced or lost, resulting in a
decreased taste. Learning buccopharyngeal, as
well as respiratory muscle sniffing may improve
sense of smell.

Communication becomes more difficult if either
the spouse or laryngectomee has impaired
hearing. Even a mild hearing loss (26-40 dB)
causes difficulty with understanding esophageal
speech, with its decreased intensity (20 dB vs.
normal 45 dB) and smaller pitch variations.
“Problem listeners” are therefore taught to
comprehend by speech reading or acquiring
hearing aids.
LARYNGECTOMY AND
FUNCTiONS

Many laryngectomy patients have other
coexistent conditions such as COPD, heart
disease, diabetes, hypertension, degenerative
joint diseases, malnutrition or other problems.
Some have additional problems related to
previous heavy use of tobacco or alcohol and
may
also
require treatment for this.
Rehabilitation can also include pain control if
necessary
through
methods
as
such
biofeedback, hypnosis.

OTHER PHYSICAL

Besides the loss of the vital functions of speech
and swallowing, there can be additional
problems due to need for breathing through a
stoma. There is no longer the use of the nose
for
moisture
and
warmth,
filtering.
Humidification helps, as dry air can cause
crusting around the stoma, mucous plugs and
increased coughing. A stoma cover can catch
any discharge from coughing or sneezing,

PSYCHOSOCIAL ASPECTS OF LARYNGEC
TOMY REHABIUTA TION
Upon learning of the diagnosis of cancer, there
is fear of cancer spread and death. Responses
to this are variable and there may be more
concern about the loss of speech. Ensuing
shock, depression and anxiety are common
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emotions. Cancer surgery is a major surgery,
often leading to functional impairment.
Successful adjustment depends on many
factors, including the background of the
individual, support of family and friends, and
the quality of rehabilitation services offered.

VOCA TIONAL
REHABILITA TION
ECONOMIC ISSUES

AND

Financial issues can be discussed with
discharge planners and social workers. There is
frequently a concern about ability to maintain
economic and vocational independence. There
may be job loss, or employment with less
prestige, income or ego satisfaction.

Although significant stress is imposed on the
family, most marriages tend to remain as stable
as those without laryngectomy. Adjustment to
the spouse’s voice and decrease in overall
communication was often more difficult than
expected. Some have had reported an alteration
in sexual function, due in part to the stoma, as
well as to effects of other treatments such as
radiation and chemotherapy.

There is an average of about five months loss
of work, while some do not return to work.
Taking early retirement in the mid-50’s is not
infrequent. This is sometimes related to
difficulties with breathing through the stoma
and the need to avoid dust, fumes and sprays,
or to speech disabilities in jobs such as
teaching, law, and construction. Having
intelligible speech was a major factor in
employment, and the desire to return to work
was a motivating factor to learn speech as
well.

Following surgery, one may alter the choice of
social activities and the poor speakers tend to
be more socially withdrawn. There may be a
loss of friends who are hard of hearing or enjoy
strenuous sports. Some never get outside of
the home and may even have no hobbies. One
may feel embarrassed, frustrated and inferior
due to physical changes, such as having a hole
in the neck for breathing.

Cancer is a life threatening disease, but one
which frequently leaves a person capable of
working. There is concern for employment
discrimination which is difficult to prove.
Employers may fear prolonged sick periods,
with increased costs for insurance, pensions
and fringe benefit plans.

Many of the psychological effects are in fact
results of social implications of a disability. The
voice serves many functions, providing com
munication and expression of emotions and
allowing gratification with mastery of situa
tions. Post-operative feelings of isolation and
body image problems can each contribute to
depression. Any form of communication lessens
depression. Those who develop functional
speech have higher levels of employment,
participate more in social activities and
community organizations and have greater
chance of returning to work.

The Americans with Disabilities Act has the
potential to prevent unfair employment
discrimination. It requires hiring and promoting
of qualified candidates with a disability, and
making “reasonable accommodations” at work.
A vocational counselor can assist with
determining possible job modifications. If one is
unable to meet the previous job requirements,
they may be eligible to retrain through state
Vocational Rehabilitation agencies.

Psychological factors important in rehabilitation
include motivation, depression sensitivity,
anxiety and
seclusion or withdrawal.
Depression differs from the normal grief
reaction, where self-esteem is not affected and
the focus is on the lost object. Frequently
depression is related to loss of speech and
diminishes with compensation for lost vocal
function. Untreated depression and poor
motivation is a common state in rehabilitation
failures and inability to acquire speech.

Following laryngectomy, there may be other
changes required in daily activities or
avocations. There may be little pleasure in
attending dinner parties due to difficulties with
speaking while eating and drinking. There may
be problems in interaction with those who have
hearing losses or in noisy environments. One
may sometimes be unable to cut grass or
shovel snow due to dust and dry or cold air.
There may be restrictions for strenuous sports
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due to reduced strength or endurance. With a
tracheostoma one should avoid water sports
without proper training
and protective
equipment, due to risk of water getting in
stoma and lungs. Caution with fishing and
boating is also required. There may be
termination of hobbies creating dust or fumes,
or an inability to pursue singing, wind
instruments, or acting.

equivalent in satisfaction to the preoperative
condition,
psychological
and
adequate
adjustment to the disability. The majority do
make a good overall adjustment and distant
laryngectomies
in
better
general
have
adjustment than those recently operated. There
was no significant differences in adjustment
among the three major speech groups
(esophageal, TEP or artificial larynx).

CONCLUSIONS

Rehabilitation can occur in a variety of settings,
such as inpatient, outpatient and home therapy,
as well as in hospice and skilled nursing
facilities if required. True rehabilitation is not
limited to the person with cancer but may
encompass education of the patient’s family
and employers as well.

Prevention of further disability is ideal,
therefore rehabilitation begins at the time of
diagnosis, with continued efforts throughout
for maximum restoration of function.
Information and support for family, spouse and
friends is related to positive rehabilitation
outcomes such as improved speech and
functioning, as well as decreased depression.
Achieving optimal functional levels includes not
only physical restoration, but optimizing social
and vocational functioning, and emotional well
being.

There is currently an increasing incidence of
tumors of the larynx, along with a more
frequent good long-term prognosis. With
advances in medical care, the majority are living
a good number of years. Although the quantity
of survival is increasing, one could pay a price
in quality issues, due to disabilities resulting
from cancer treatment side effects. A better
quality of survival can be achieved through a
coordinated rehabilitation program. For further
information on this topic or related issues,
please contact me or any of the members of
the Rehabilitation Services Department at West
Allis Memorial Hospital.

There is a unique nature of the loss of voice,
with its additional psychological, social and
economic implications. Restoring optimal
function in those treated for laryngeal tumors is
important in rehabilitation. Signs of successful
rehabilitation include effective communication
regardless of the method, a return to a life-style
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PA TIENT CARE EVALUATION STUDIES OF THE LARYNX AND HYPOPHARYNX
Hospital Participation

Comparative Results

In 1 994 our hospital participated in the
Commission on Cancer’s studies of laryngeal
and hypopharyngeal cancers. Our hospital was
among 723 hospitals that contributed 11 ,407
casesfortheshort-term (1992) study, and 519
hospitals that contributed 8,554 cases for the
long-term (1985) survival study.

When compared with the other hospitals,
WAMH patients were older at the time of
diagnosis in the majority of the cases. This is a
disease of patients in the 60 to 79 age range.
The sex ratio is predominantly male. WAMH
figures all reflect this. Males account for over
70 to 84 percent of the incidence of these
cancers. These percentages are reflected in the
national figures as well.

Purpose of the Studies
The purposes of the studies are to document
current methods of diagnosis, staging and
treatment of the larynx and hypopharyngeal
cancers. The survival study will assess the
results of treatment.

Risk Factors
Whether the patient had ever smoked or was a
current smoker was recorded as yes. The
graph on the next page demonstrates that the
overwhelming majority of patients from WAMH
had a history of smoking. This fact was also
present in the data from the other hospitals.

Eligibility
Patients entered in the studies must meet the
following criteria:

Both the 1985 and 1990 WAMH study results
have shown that 32 percent of the patients
reported a weekly alcohol consumption of at
least 21 drinks or more. What is not apparent
in the WAMH study results is the fact that
many patients had a history of ETOH abuse but
at the time of diagnosis were not drinking.
This information was not requested in the
studies so these facts are not indicated in the
data.

Cancer must be a histologically confirmed
primary of the larynx or hypopharynx.
Patients must either be first diagnosed and
treated at WAMH, or had their first course of
therapy initiated at WAMH. Also included are
those patients for whom no treatment was the
treatment of choice.
Excluded are those patients diagnosed at
WAMH who received their first course of
therapy at another facility and those diagnosed
at autopsy.

As shown in the national data results there was
a high percentage of unknown weekly alcohol
consumption, while the WAMH percentage of
unknown was relatively small. This would
seem to indicate that more complete documen
tation was present in the medical records at
WAM H.

Only epithelial carcinomas of the larynx and
hypopharynx were eligible to be included in the
studies.
Each study includes 25 consecutive cases
accessioned in both 1985 and 1992.
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LARYNGEAL AND HYPOPHARYNX CANCER STUDIES
PATIENT AGE

PERCENTAGE
70

STUDY-WAMH
D1990 STUDY-WAMH

60

U1985 STUDY-NAT’L
*1990 STUDY-NAiL

50
40

40
30

25

20
10
0

99

<50

50-59

70-79

60-69

AGE RANGE

24

80-89

90>

LARYNGEAL AND HYPOPHARYNX CANCER STUDIES
WEEKLY ALCOHOL CON$UMPTION*
ALL OTHER
HOSPITALS

WEST ALLIS MEMORIAL
HOSPITAL

NUMBER OF
DRINKS

1985 STUDY

WEEKLY AMT.

10 (40%)

NONE

-0-

4-6

2226 (20%)

1191 (14%)

15 (60%)

2 (8%)

1-3

1990 STUDY

1985 STUDY

1990 STUDY

-0-

122

(1%)

226

(2%)

-0-

62

(1%)

127

(1%)

7-73

1

(4%)

-0-

195

(2%)

308

(3%)

14-20

1

(4%)

-0-

234

(3%)

323

(3%)

21 -27

2 (8%)

3 (12%)

181

(2%)

272

(2%)

6 (24%)

5 (20%)

609

(7%)

849

(7%)

3 (12%)

2 (8%)

28

-

>

UNKNOWN
OTHER

-

0

-

-

25 (100%)

TOTALS

0

5879
87

-

6977

(69%)

99

(1%)

* These results do not take into account those patients with a history weekly alcohol consumption.

LARYNGEAL AND HYPOPHARYNX CANCER STUDIES

jJ

PATIENT SMOKING HISTORY

YES 96%

YES 88%
—UNRNOWN

WAMH

-

—NO NEVER 12%

WAMH

1985

YES 81%

‘—NO NEVER 6%

11LuNKNowN 14%

-

1990

YES 88%

—OTHER 1%

ALL HOSPITALS

-

\3LNKNOWN 6%

1985

ALL HOSPITALS

25

-

1990

(1%)

11,407 (100%)

8554 (100%)

25 (100%)

(61%)

LARYNGEAL AND HYPOPHARYNX CANCER STUDIES
FIRST COURSE OF THERAPY
N

PERCENT

120

/

ELARYNX
ELARYNX

-

-

1985
1990

DHYPOPHARYNX

-

100
-

1985
1990

80

60

40
20
20

0

/

/
SURGICAL RESECT

RADIATION THERAPY

CHEMOTHERAPY

WEST ALLIS MEMORIAL

Symptoms Present at Diagnosis
First Course of Therapy

It is interesting to note that there are relatively
few symptoms present at the time of diagnosis
for laryngeal cancer when compared to hypo
pharyngeal cancer and yet laryngeal cancer is
diagnosed at an earlier stage than hypopharyn
geal cancer. The results are essentially the
same when WAMH is compared to the national
results. The main symptom present in laryng
eal cancer is hoarseness while the main
symptoms present at diagnosis in hypopharyn
geal cancer are dysphagia, neck mass, and sore
throat.
Survival

The graph above shows an increase, in 1 990,
of 25 percent in the use of radiation therapy for
treatment of cancer of the larynx and a
decrease of 25 percent in the use of surgical
resection. Twenty-five percent of the patients
received a combination of surgery and radiation
therapy for laryngeal cancer in 1990.
The treatment for cancer of the hypopharynx
remained relatively unchanged when comparing
the 1985 and 1990 data. It is interesting to
note that, in 1985, 20 percent of the patients
with hypopharyngeal cancer received chemo
therapy which coincided with 20 percent of the
patients with stage IV cancer. In 1990, 60
percent of the patients had stage IV cancer of
the hypopharynx and none were treated with
chemotherapy.

When comparing the survival graphs for both
hypopharyngeal and laryngeal cancer WAMH
survival results compared favorably with the
national results.
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HYPOPHARYNX CANCER sTUDIEiT1
SYMPTOMS PRESENT AT DIAGNOSIS
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HYPOPHARYNGEAL CANCER STUDIES
CLINICAL A]CC TNM STAGE

j

STAGE 0

STAGE I

20

1985

20

STAGE II

p20:

40

STAGE III

STAGE IV

20

50

40

30

20

60
10

0

10 20 30 40 50 60 70

PERCENT

WEST ALLIS MEMORIAL

28

HYPOPHARYNGEAL CANCER STUDIESh
FIVE YEAR LONG-TERM SURVIVAL
WAMH ALL HOSPITALS

PERCENT

100
80
60
40
20
0
WAMH
ALL HOSPITALs

<1 YR

1-<2YR

2-<3YP

3-<4YR

4-<5YR

80

57.1

57.1

57.1

57.1

19

69.1

49

38.9

34.8

33.1

28.6

5>YR

LARYNGEAL CANCER STUDIES

L

FIVE YEAR LONG-TERM SURVIVAL

WAMH 9ALL HOSPITALS

PERCENT

b
1:o

WAMH
4JOSPITALS

<I YR

1-<2YR

2-<3YR

3-<4YR

4-<5YR

5>YR

94.6

76.9

76.9

76.9

76.9

76.9

91.5

83.5

79.2

76.6

74.7

69.7
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GLOSSARY

Accessioned

Entered into the Cancer Registry data base

ACoS

American College of Surgeons In 1 932 the American Cancer Society
urged the American College of Surgeons to take the lead in setting
guidelines for cancer care. Approval of hospital-based cancer programs
has been the foundation for improving the quality of care of patients
with cancer.

ACS

American Cancer Society

AJCC

American Joint Committee on Cancer organized for cancer staging and
end results reporting

First Course of Therapy

First course of therapy is treatment planned and/or administered within
the first four months following cancer diagnosis in order to modify,
control, remove or destroy proliferating cancer tissue.

PCE’s

Patient care evaluation studies Evaluation of cancer patient care
through the process of problem identification, problem analysis, action
planning and follow-up monitoring.

Stage of Disease

The extent of disease determined at the time of initial workup for the
first course of treatment

Subsequent Therapy

Change in treatment due to apparent failure of the original, planned or
administered treatment or because of progression of disease, such
treatment is excluded from the first course of therapy.

TNM Staging

AJCC classification to determine the extent of disease at the time of
diagnostic workup for the first course of treatment
T Size of tumor
N Lymph node involvement
M Metastasis at distant sites

-

-

-

-

-

-
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